Oxidative pathways in cardiovascular disease: Roles, mechanisms, and therapeutic implications

Pharmacology and Therapeutics

Volumn 89, Issue 2, 2001, Pages 187-206

  Wattanapitayakul, Suvara Kimnite ^a   Bauer, John Anthony ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Cardiovascular disease; Nitric oxide; Oxidants; Peroxynitrite; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BETA CAROTENE; COLESTIPOL; CYTOKINE; FATTY ACID; GLUTATHIONE; LIPOPROTEIN; NICOTINIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINOL; RETINOL PALMITATE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

APOPTOSIS; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CELL DEATH; CELL INFILTRATION; CORONARY ARTERY DISEASE; DISEASE COURSE; ELECTRON TRANSPORT; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE NECROSIS; HUMAN; HYPERTENSION; LIPID METABOLISM; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CELL DEATH; DIETARY SUPPLEMENTS; HUMANS; NITRIC OXIDE; OXIDANTS; REACTIVE OXYGEN SPECIES;

EID: 0035055046     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00114-5     Document Type: Review

References (194)

1. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
2. Reperfusion injury: Experimental evidence and clinical implications
3. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart
4. Apoptosis and myocardial infarction
5. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
6. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production
7. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells
8. Oxidative damage and tyrosine nitration from peroxynitrite
9. Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors
10. Protein oxidation in aging, disease, and oxidative stress
11. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
12. Protective influence of pretreatment with allopurinol on myocardial function in patients undergoing coronary artery surgery
13. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production
14. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options
15. Lipid-lowering therapy
16. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts
17. Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury
18. Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia
19. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite
20. p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function
21. Nicardipine normalizes elevated levels of antioxidant activity in response to xanthine oxidase-induced oxidative stress in hypertensive rat heart
22. Tissue damage in acute myocardial infarction: Selective protection by vitamin E
23. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery
24. Targets of oxidative stress in cardiovascular system
25. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes
26. Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo
27. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy
28. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting
29. Bioavailability of vitamin E
30. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species
31. Nutriceuticals for cardiovascular health
32. Regulation of gene expression by reactive oxygen
33. Dietary vitamin C, beta-carotene and 30-year risk of stroke: Results from the Western Electric Study
34. Xanthine oxidoreductase activity in perfused hearts of various species, including humans
35. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)
36. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes
37. Role of oxidative stress in transition of hypertrophy to heart failure
38. Antioxidants and atherosclerotic heart disease
39. Increased malondialdehyde in peripheral blood of patients with congestive heart failure
40. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension
41. Altered serum concentrations of TGF-beta 1 and Lp(a) lipoprotein and their correlation in patients with first acute myocardial infarction
42. Vitamin C intake and mortality among a sample of the United States population
43. Chromosomal aberrations and neutrophil activation induced by reperfusion in the ischaemic human heart
44. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts
45. Oxidative stress during myocardial ischaemia and heart failure
46. Beta-blockers in congestive heart failure: The pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure
47. Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol
48. Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite
49. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension
50. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: Their relation to lesion site and beta-adrenergic receptor therapy
51. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people
52. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease
53. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation
54. Redox control of vascular smooth muscle proliferation
55. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
56. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
57. Fatty acid oxidation in the heart
58. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion
59. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: Presumptive evidence for an interaction between vitamins C and E in vivo
60. Potential new cardiovascular risk factors: Left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen
61. Endothelial function and oxidant stress
62. Signaling pathways in cardiac myocyte hypertrophy
63. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells
64. Free fatty acid metabolism during myocardial ischemia and reperfusion
65. Increasing burden of cardiovascular disease: Current knowledge and future directions for research on risk factors
66. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
67. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: Possible role of reactive oxygen species
68. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese
69. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
70. Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria
71. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling
72. Ascorbic acid enhances endothelial nitric oxide synthase activity by increasing intracellular tetrahydrobiopterin
73. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation
74. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x
75. Influence of simulated ischemia on apoptosis induction by oxidative stress in adult cardiomyocytes of rats
76. Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease
77. Antioxidant defences in rat, pig, guinea pig, and human hearts: Comparison with xanthine oxidoreductase activity
78. Deposition of oxidized low-density lipoprotein and collagenosis occur coincidentally in human coronary stenosis: An immunohistochemical study of atherectomy
79. Expression and regulation of adhesion molecules in cardiac cells by cytokines: Response to acute hypoxia
80. Redox regulation of cellular signalling
81. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans
82. Oxygen free radicals and calcium homeostasis in the heart
83. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration
84. Cardiac depression and cellular injury in hemorrhagic shock and reinfusion: Role of free radicals
85. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation
86. Increased oxidative stress in patients with congestive heart failure
87. Vitamin E levels in human atherosclerotic plaque: The influence of risk factors
88. Nitric oxide as a bifunctional regulator of apoptosis
89. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function
90. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent
91. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: The role of alpha-carotene and gamma-tocopherol
92. Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite
93. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
94. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells
95. Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia
96. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
97. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension
98. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study
99. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury
100. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans
101. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria
102. Criteria and recommendations for vitamin C intake
103. Nitrates
104. Uric acid in chronic heart failure: A marker of chronic inflammation
105. Alteration of endogenous antioxidant enzymes in naturally occurring hypertrophic cardiomyopathy
106. Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart
107. Vitamin C status and mortality in US adults
108. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines
109. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins
110. Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease
111. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
112. Kinetics of tissue alpha-tocopherol uptake and depletion following administration of high levels of vitamin E
113. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
114. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite
115. IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells
116. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension
117. Relationship between mechanical dysfunction and depression of sarcolemmal Ca(2+)-pump activity in hearts perfused with oxygen free radicals
118. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction
119. Effects of oxidant stress on steady-state background currents in isolated ventricular myocytes
120. Membrane potential fluctuations and transient inward currents induced by reactive oxygen intermediates in isolated rabbit ventricular cells
121. Free radicals and antioxidants in cardiovascular disease
122. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage
123. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia
124. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis
125. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1
126. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta
127. Consumption of vitamin E in coronary circulation in patients with variant angina
128. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients
129. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
130. Antioxidative vitamins in prevention of ischemia/reperfusion injury
131. Interaction among vitamin C, vitamin E, and beta-carotene
132. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
133. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease
134. Cytokines and cardiomyocyte death
135. Oral vitamin C and endothelial function in smokers: Short-term improvement, but no sustained beneficial effect
136. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
137. Protection of coronary angioplasty-induced oxidative stress by Isovue used during angioplasty
138. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
139. Vitamin E consumption and the risk of coronary heart disease in men
140. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle
141. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: Beneficial effects of bezafibrate treatment
142. Nitric oxide in the failing myocardium
143. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function
144. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha
145. Antioxidant and redox regulation of gene transcription
146. Congestive heart failure
147. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults: The Third National Health and Nutrition Examination Survey (NHANES III)
148. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions
149. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
150. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides
151. Cardiac fatty acid metabolism and the induction of apoptosis
152. Vitamin E consumption and the risk of coronary disease in women
153. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
154. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors
155. Regulation of mitogen-activated protein kinase cascades in the heart
156. Redox regulation of transcriptional activators
157. 2 for platelet-derived growth factor signal transduction
158. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats
159. Oxidants as stimulators of signal transduction
160. Induction of necrosis but not apoptosis after anoxia and reoxygenation in isolated adult cardiomyocytes of rat
161. 2+ overload in reperfused ischemic myocardium
162. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty
163. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart
164. L-Arginine: Rediscovery in progress
165. 2- efflux which injures endothelial cells by an extracellular mechanism
166. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity
167. In vitro study of the cytotoxicity of isolated oxidized lipid low-density lipoproteins fractions in human endothelial cells: Relationship with the glutathione status and cell morphology
168. Possible prevention of postangioplasty restenosis by ascorbic acid
169. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
170. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association
171. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction
172. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement
173. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy
174. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes
175. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes
176. Bioavailability of lutein from vegetables is 5 times higher than that of beta-carotene
177. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome
178. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis
179. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease
180. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population
181. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders
182. Genetic variations in nitric oxide synthase isoforms
183. Vitamin E and human health: Rationale for determining recommended intake levels
184. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction
185. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans
186. Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: A randomized, factorial design, placebo-controlled trial
187. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine
188. 2-induced tyrosine phosphorylation of protein kinase cδ by a mechanism independent of inhibition of protein-tyrosine phosphatase in CHO and COS-7 cells
189. Signalling pathways for cardiac hypertrophy
190. Vitamin E supplementation and cardiovascular events in high-risk patients
191. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
192. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass
193. Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells